跳至主要内容
临床试验/JPRN-UMIN000002622
JPRN-UMIN000002622已完成2 期

Pemetrexed Monotherapy for Performance Status 2 Patients in Treatment of Non-Small and Non-Squamous Cell Lung Cancer Patients Without EGFR Mutation. - Pemetrexed Monotherapy for Performance Status 2 Patients

Kobe Lung Cancer Oncology Study Group (KLOG)0 个研究点目标入组 35 人开始时间: 2009年10月15日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
35

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)Interstitial pneumonia or pulmonary fibrosis detectable on CT scan 2)History of drug induced interstitial pneumonia 3)History of severe drug allergy 4)History of active infection or other serious disease condition (GI bleeding,etc.) 5)History of poorly controlled pleural effusion,pericardial effusion and ascites 6)History of severe heart disease(uncontrollable arrythmia,uncontrollable angina pectoris,herat failure,etc.) 7)Uncontrollable diabetes mellitus 8)History of symptomatic brain metastases 9)Hystory of active double cancer 10)History of active psychological disease 11)Patients whose participation in the trial is judged to be inappropriate by the attending doctor

研究者

发起方
Kobe Lung Cancer Oncology Study Group (KLOG)

相似试验